BioSpace News Archive

BioMidwest

Digital Authority Partners Looks Beyond the Resume, Wins Timmy Award for Best Tech Workplace for Diversity

Chicago’s Fourth Annual Timmy Awards, presented by Tech in Motion, has officially awarded Digital Authority Partners Best Tech Workplace for Diversity in 2018.

November 5, 2018
·
3 min read
Business

Myomo Announces Third Quarter 2018 Financial Results

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today reports its financial results for the third quarter ended September 30, 2018.

November 5, 2018
·
13 min read
Business

Dicerna Reports Third Quarter 2018 Financial and Operating Results and Provides Corporate Update

Demonstrated Clinical POC for DCR-PHXC in Primary Hyperoxaluria and On Track to Initiate Registration Trial in Q1 2019

November 5, 2018
·
17 min read
bioLIVE to merge with BioProduction Congress for 2019 event

BioProduction’s content platform will be added to the bioLIVE exhibition, creating one of the world’s largest event hubs for the bio industry

November 5, 2018
·
5 min read
Business

YUHAN ANNOUNCES LICENSE AND COLLABORATION AGREEMENT WITH JANSSEN FOR A NOVEL, INVESTIGATIONAL LUNG CANCER THERAPY

Yuhan will receive an upfront payment of $50 million and is eligible to receive up to $1,205 million in potential development and commercial milestone payments, along with tiered double-digit royalties on future net sales.

November 5, 2018
·
2 min read
Genetown

Akcea Recognizes First Global Familial Chylomicronemia Syndrome (FCS) Awareness Day

Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., today recognizes the inaugural Familial Chylomicronemia Syndrome (FCS) Awareness Day on November 2, 2018.

November 5, 2018
·
5 min read
Business

Lilly and NextCure Announce Collaboration to Discover and Develop Novel Immuno-Oncology Medicines

Eli Lilly and Company (NYSE: LLY) and NextCure, Inc. today announced a multi-year collaboration focused on the discovery and development of immuno-oncology therapies.

November 5, 2018
·
5 min read
Business

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) on November 1, 2018

Verastem, Inc. today announced the grant of options to purchase 6,153 shares of its common stock to one new employee and 40,000 restricted stock units (RSUs) to another new employee.

November 5, 2018
·
2 min read
NOVARUM TO EXPLORE SMARTPHONE TECHNOLOGY’S ROLE IN ANTIBIOTIC STEWARDSHIP AT UK DIAGNOSTICS SUMMIT

The one-day summit will bring together over 150 diagnostic specialists in academia and industry, which includes end-users within the pharmaceutical and healthcare profession.

November 5, 2018
·
2 min read
CRH Medical Receives TSX Approval for Renewal of Normal Course Issuer Bid

CRH Medical Corporation (the “Company”) (TSX: CRH) (NYSE American: CRHM), announces that it has received approval from the Toronto Stock Exchange (“TSX”) of its Notice of Intention to renew its existing Normal Course Issuer Bid (the “Bid”).

November 5, 2018
·
12 min read